Related Experiment Video
Updated: May 11, 2026
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment
Grit S Herter-Sprie1, Heidi Greulich, Kwok-Kin Wong
1Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA, USA ; Department of Medicine, Harvard Medical School Boston, MA, USA.
Frontiers in Oncology
|May 1, 2013
Summary
Targeting ERBB2 (also known as HER2) mutations is crucial for developing new cancer therapies. This review explores how these mutations activate the ERBB2 receptor and discusses current treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer remains a leading cause of death despite extensive research.
- Targeted therapies offer a promising future for cancer treatment, emphasizing the need for tumor-specific targets.
- ERBB2/HER2 is implicated in various cancers, including breast, ovarian, gastric, and lung tumors.
Purpose of the Study:
- To review the functional role of somatic mutations in ERBB2 receptor activation.
- To discuss current preclinical and clinical therapeutic strategies targeting mutationally activated ERBB2.
Main Methods:
- Review of scientific literature focusing on ERBB2 mutations and targeted therapies.
- Analysis of next-generation sequencing data for identifying ERBB2 alterations.
- Discussion of preclinical and clinical studies on ERBB2-targeted treatments.
Main Results:
- Somatic mutations can lead to aberrant activation of the ERBB2 receptor.
- Next-generation sequencing facilitates the identification of these activating ERBB2 mutations.
- Targeted therapies, including antibody and small molecule inhibitors, are being developed.
Conclusions:
- Targeting mutated ERBB2 represents a key strategy in precision oncology.
- Understanding the functional impact of ERBB2 mutations is vital for effective therapeutic development.
- Further research into preclinical and clinical strategies is essential for optimizing treatment outcomes.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...